Table 4: Distribution of laboratory findings during follow-up in patients < 65 and ≥65 years according to diabetes mellitus development.
|
Age |
Variables |
Diabetes Mellitus Developed |
|
Diabetes Mellitus Not – Developed |
|
Δp |
||||
|
Basal |
II. visit |
p |
|
Basal |
II. visit |
p |
|
|||
|
<65 |
FBG |
114.8±8.1 |
147.3±47.2 |
0.009* |
|
104.4±9.6 |
104.3±11.6 |
0.95 |
|
<0.001* |
|
HbA1c |
6.3±0.8 |
6.6±0.8 |
0.460 |
|
5.9±0.4 |
5.9±0.5 |
0.996 |
|
0.322 |
|
|
Uric acid |
5(3.8-6.5) |
4.7(3.4-5.8) |
0.302 |
|
5.1(2.3-8.3) |
5.3(1.5-7.4) |
0.605 |
|
0.416 |
|
|
Total bilirubin |
0.5(0.3-1.4) |
0.4(0.2-0.7) |
0.105 |
|
0.5(0.1-1.3) |
0.4(0.1-1.4) |
0.305 |
|
0.705 |
|
|
Direct bilirubin |
0.1(0.1-0.4) |
0.2(0.1-0.4) |
0.160 |
|
0.1(0-1.4) |
0.1(0-1.1) |
0.412 |
|
0.806 |
|
|
≥65 |
AKŞ |
109±11 |
144.8±46.2 |
0.022* |
|
104.1±7.4 |
108.9±22 |
0.980 |
|
0.001* |
|
HbA1c |
6.0±0.1 |
6.5±0.6 |
0.753 |
|
6.1±0.3 |
5.6±0.8 |
0.104 |
|
0.114 |
|
|
Uric acid |
5.7(4.2-7.2) |
5.4(3.2-8.4) |
0.850 |
|
5(3.2-10.9) |
4.8(3.3-8.5) |
0.322 |
|
0.229 |
|
|
Total bilirubin |
0.6(0.2-0.7) |
0.6(0.3-1.1) |
0.940 |
|
0.7(0.3-1.1) |
0.5(0.1-0.9) |
0.042* |
|
0.036* |
|
|
Direct bilirubin |
0.1(0.1-0.3) |
0.1(0.1-0.4) |
0.912 |
|
0.1(0.1-0.8) |
0.2(0.1-0.3) |
0.088 |
|
0.105 |
|
Categorical variables were expressed as numbers and percentage, numerical variables were expressed as mean±standard deviation or median (min-max).
*p < 0.05 was considered statistically significant.
FBG: Fasting Blood Glucose, HbA1c: Glycosylated Hemoglobin